Table 1.
Percentages of lymphocyte subsets in the peripheral blood of patients with metastatic breast cancer and healthy controls
| Subset % | Patients cohort (N = 89) | Healthy controls (N = 50) | T value | P value |
|---|---|---|---|---|
| CD3+ | 59.1 ± 11.3 | 69.05 ± 8.0 | −8.354 | <0.0001 |
| CD3+/CD4+ | 32.5 ± 8.2 | 33.7 ± 7.9 | −1.382 | 0.171 |
| CD3+/CD8+ | 23.7 ± 7.7 | 23.85 ± 5.75 | −0.145 | 0.885 |
| CD8+/CD28+ | 11.0 ± 4.9 | 12.05 ± 3.5 | −2.038 | 0.045 |
| CD8+/CD28− | 21.3 ± 8.0 | 17.35 ± 7.45 | 4.660 | <0.0001 |
| CD4+/CD25+ | 9.6 ± 4.6 | 5.4 ± 2.7 | 9.520 | <0.0001 |
| CD3−/CD56+ | 16.9 ± 8.2 | 16.8 ± 8.7 | 0.087 | 0.9310 |
| CD19+ | 13.6 ± 6.1 | 12.7 ± 5.4 | 1.272 | 0.207 |
Values represent the mean ± SD
P values were calculated by Student’s t test